3 FTSE stocks I’d stockpile during the coronavirus pandemic

G A Chester highlights two resilient FTSE 100 stocks and a solid, smaller-cap company that could deliver high long-term growth and returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The coronavirus outbreak has become a pandemic, and the toll on human and economic life is rising. We’ve seen panic-buying in supermarkets, and panic-selling in stock markets.

The FTSE 100 doesn’t crash 30% in the space of a month without a great deal of fear and panic around. Yet I’m convinced this is the wrong time to be dumping shares. Indeed, I think long-term investors should be doing exactly the reverse. With this in mind, I wouldn’t recommend stockpiling groceries, but here are three FTSE stocks I’d stockpile during this market crash.

Attractive qualities

It may not be a household name, like BP, Lloyds or Vodafone, but Halma (LSE: HLMA) is a FTSE 100 group with highly attractive qualities for investors.

Its businesses are focused on delivering a safer, cleaner and healthier future for people worldwide. It operates in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. These have long-term drivers for growth and high returns.

The company issued a trading update yesterday, ahead of its financial year-end of 31 March. It hasn’t been immune to the impact of Covid-19. It advised it now expects adjusted profit before tax of £265m-£270m, compared with a City consensus forecast of £275.5m.

According to my sums, this translates into earnings per share (EPS) of around 56p. At a share price of 1,930p, the price-to-earnings (P/E) ratio is 34.5. This, together with a 1% yield on what I reckon will be a dividend of around 16.8p, may suggest an overly rich valuation. However, I believe the stock is worth buying for its relative resilience, and history — and long-term prospects — of strong growth.

Often overlooked

Hikma Pharmaceuticals (LSE: HIK) is another lesser known FTSE 100 stock. Certainly it’s often overlooked, due to the presence of super-heavyweight sector peers AstraZeneca and GlaxoSmithKline. However, I believe Hikma merits much greater interest from investors, and that the stock is very buyable today.

The company issued strong annual results on 27 February, with growth across all three of its Injectables, Generics and Branded business segments. It had little to say on the coronavirus at that time, it having no extensive operations or manufacturing in China.

However, management said it’s continually monitoring the situation. We may get an update before its next scheduled statement on 30 April. Either way, I see Hikma as another relatively resilient business, with excellent long-term growth prospects.

At a share price of 1,900p, it trades at a P/E of 15 on current City forecasts of 127p EPS for 2020. A forecast dividend of 36p gives a yield of 1.9%.

Solid smaller-cap

There are some solid, small-caps trading at nice discounts right now. Alliance Pharma (LSE: APH) is certainly one smaller FTSE stock I’d happily buy today.

In a full-year trading update, the company reported revenue for its Local brands slightly ahead of the prior year, but very strong growth across its International Star brands. These include Kelo-cote (a scar treatment product), and Nizoral (a medicated anti-dandruff shampoo).

The trading update was on 22 January, but we’ll get the full results — and doubtless a first statement from management on the coronavirus — next Tuesday. I expect the business will be impacted to some extent. However, at a share price of 65p, Alliance is trading at an attractive P/E of 13 on a consensus EPS forecast of 5p. There’s also a yield of 2.5% on a predicted 1.6p dividend.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Alliance Pharma, AstraZeneca, Halma, Hikma Pharmaceuticals, and Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »